- iRadimed press release (IRMD): Q2 Revenue of $20.46M.
-
For the three months ended June 30, 2026, cash flow from operations was $5.9 million, compared to $7.7 million for the comparable period of 2025, a decrease of 23%. During the three months ended June 30, 2026, cash provided by operations was
iRadimed reports Q2 results (IRMD:NASDAQ)
